David O. Taylor is listed as an executive officer, director, and promoter on 6 SEC Form D filings by 2 issuers between Jul 2009 and Oct 2023: Sparxent, Inc (Salt Lake City, UT — computers — 2009; $16.8M reported sold to 30 investors) and Biolexis Therapeutics Inc. (Lehi, UT — biotechnology — 2022–2023; $1.6M reported sold to 17 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 14 years. Across those companies the filings report $18.4M sold in total.
1 of the issuers belongs to the sponsor group Halia (2 issuers, $5.09M reported sold, 2020–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Halia has 2 companies on file and $5.09M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 SEC releases, 5 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 6 public filings for David O. Taylor and found 14 differences: Form D filed 26 days after the first sale; David O. Taylor's role changed at Biolexis Therapeutics Inc.: executive officer → executive officer, director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.